SiriusPoint earnings date
Want to see SPNT full AI Analyst Report?
SiriusPoint (SPNT) Q3 2026 Earnings Report
SPNT Q3 2026 EPS Results
- Actual EPS
- $0.88
- Consensus EPS
- $0.64
- Beat/Miss
- Beat by +$0.24
- One Year Ago EPS
- $0.72
SPNT Q3 2026 Revenue Results
- Actual Revenue
- $867.60M
- Expected Revenue
- $740.99M
- Beat/Miss
- Beat by +$126.61M
- YoY Revenue Growth
- +14.78%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/05/2026
- Time
- After Close
- Conference Call
- Thursday, November 5, 2026
SiriusPoint's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
The call was strongly positive. SiriusPoint reported attractive underwriting margins, operating returns above its 12% to 15% target, premium and earnings growth, favorable reserve development, strong capital and liquidity, and an encouraging growth pipeline. The LPT was presented as a major step in reducing legacy uncertainty and releasing capital, although it carries an approximately $60 million day-one cost, requires regulatory approval, and leaves a claims-administration tail. Competitive pricing, lower year-to-date reinsurance premiums, selected program nonrenewals, and pressure in property catastrophe and other lines were acknowledged, but management emphasized disciplined portfolio management and continued opportunities for profitable growth.
Management stated a 12% to 15% ROE target range and said the LPT reinforces the company's ability and confidence to meet or outperform that range going forward; A&H premiums are expected to return to low single digit growth in the fourth quarter, specialty P&C premiums are expected to be modestly lower year over year in the fourth quarter, with growth expected to resume in 2027, and the 2027 pipeline remains encouraging. Within US medical, excess of loss, rate expectations are in excess of 20%, while major airlines are expected to see double digit rate increases during the fourth quarter renewal season; property catastrophe reinsurance, approximately 4% of the portfolio, is expected to face continued pricing pressure. Claims administration costs are expected to be around $15, $16 million a year and come down over roughly a 3-year period, with about a 3-year, 2.5- to 3-year, tail; the LPT has an expected day 1 cost of approximately $60 million and is expected to increase the BSCR ratio by approximately 20 points on a pro-forma basis upon close. Management said it would ideally complete the LPT in Q4, though it could slip into Q1, and expects to restart repurchases, with at least whether it is a meaningful component or all of the remaining authorization executed between now and the end of the year, with a component potentially trickling over into 1 queue.
- Strong Third-Quarter Profitability and ReturnsSiriusPoint reported a core combined ratio of 90.1% in the third quarter, underwriting income of $76 million, operating net income of $103 million, and operating return on equity of 17.6%, above the company's 12% to 15% target range.
- Solid Nine-Month PerformanceFor the first nine months, insurance and services grew 14%, core gross written premium grew 7% to nearly $3 billion, core underwriting income increased 22% to $202 million, and operating return on equity was 15.8%, above the 12% to 15% target range.
- Premium Growth and Underwriting Income ImprovementThird-quarter core gross written premium increased 14% to $991 million, earned premiums increased 19%, and underwriting income increased 9% year over year to $76 million.
- Growth in Services and Fee-Based EarningsNet services fee income increased 21% year over year to $12 million, with growth of 44% on an adjusted, go-forward MGA basis.
- Operating Earnings and Book Value GrowthOperating earnings per diluted share increased 19% year over year to $0.88 in the third quarter and increased 17% year over year to $2.29 for the first nine months. Diluted book value per share excluding AOCI increased $0.73 during the quarter to $20.21, was up 12% in the first nine months, and has compounded at a 19% annual rate over the last three years.
- Strong Core Operating ROECore operating ROE, which excludes the runoff portfolio result, was 18.1% for the quarter and 17% for the first nine months. Management said it has exceeded the 12% to 15% target for the past two years.
- Insurance and Services Segment GrowthInsurance and services gross written premium grew 20% in the third quarter, driven by credit, surety, and increases in premium estimates for FinPro. The segment reported a 92.8% combined ratio for the quarter and 92% year to date.
- Improved Reinsurance Underwriting ResultsReinsurance gross written premium returned to growth, increasing 3% in the quarter. The reinsurance combined ratio improved 1.9 percentage points in the quarter and 4.3 points year to date, primarily due to lower catastrophe losses.
- Attractive Accident and Health PositionAccident and health represents 26% of premium mix and was described as having attractive profitability, relatively low capital intensity, and low correlation with P&C market cycles. Employer stop loss showed signs of firming, US medical excess-of-loss rate expectations were in excess of 20%, and management said the broader A&H portfolio was carrying rates at least in line with, and in some cases slightly more than, claims inflation.
- Strength in Selected Specialty LinesManagement cited disciplined pricing in general liability, stable surety pricing with attractive diversification, strong growth supported by favorable market conditions in credit, and strong growth and performance in environmental business. Aviation was expected to see double-digit rate increases for major airlines during the fourth-quarter renewal season.
- Disciplined Portfolio ManagementThe company is growing in accident and health, surety, credit, and selected P&C opportunities while reducing exposure where risk-adjusted returns are less compelling. Management specifically described reducing participation in aviation and property catastrophe reinsurance and reallocating capital toward more attractive opportunities.
- Encouraging 2027 PipelineManagement described the 2027 pipeline as healthy and encouraging, particularly in the NGA global programs business and A&H. Opportunities cited included IMG and employer stop loss, where capacity has reduced in the marketplace.
- Strategic Importance of Reinsurance MaintainedManagement said reinsurance remains strategically important and that the company is willing to deploy capital where it sees attractive returns, including blended reinsurance and insurance solutions for clients.
- Loss Portfolio Transfer AgreementSiriusPoint entered into a loss portfolio transfer agreement with Riverstone that is expected to substantially cover remaining runoff exposures. Subject to customary regulatory approvals, management expects runoff exposures to be at de minimis levels and described the transaction as closing the chapter on the legacy book.
- Reduction in Legacy Reserve UncertaintyThe runoff portfolio relates to business written before 2023, and pure underwriting losses excluding claims administration expenses totaled $60 million since 2024. Management said the LPT mitigates this uncertainty, and that runoff losses are expected to have a negligible impact on a go-forward basis.
- Capital Released by the LPTThe LPT is expected to free up more than $200 million of capital upon completion and increase the BSCR ratio by approximately 20 percentage points on a pro forma basis.
- Strong Balance Sheet and LiquidityThe estimated BSCR ratio was 232%, debt to capital was 23%, and liquidity was approximately $1 billion. Management said the balance sheet provides flexibility to fund the business, pursue market opportunities, support profitable growth, and return excess capital to shareholders.
- Shareholder Capital ReturnsThe company returned $300 million in 2026, in addition to $1 billion returned through strategic capital actions between 2024 and 2025. It repurchased $27 million of common shares during the quarter, with $74 million remaining under the authorization, and plans to resume repurchases.
- High-Quality Investment PortfolioFor the first nine months, net investment income was $198 million and total investment income was $220 million. Average credit quality was double-A-minus, approximately 99% of the portfolio was investment grade, there were no fixed-income defaults during the period, and the reinvestment rate exceeded 5% during the quarter.
- Consistent Favorable Prior-Year DevelopmentThe company recorded its 22nd consecutive quarter of favorable prior-year development, with favorable development in the third quarter coming from A&H, energy, credit, and property. Management attributed the track record to a prudent reserving approach, including reserving above pricing projections in some newer MGA relationships.
- Segment Reporting RealignmentBeginning in the fourth quarter, SiriusPoint plans to report Accident and Health as a standalone segment and combine the remaining nine specialties into a new specialty P&C segment. Management said both segments currently operate at combined ratios in the low nineties and that the change will better reflect how the business is managed.
- Experienced Board AppointmentJohn Sutherland joined the board of directors, bringing more than 35 years of insurance industry experience and prior service as chief financial officer of Progressive.
SPNT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | 0.59- | 0.7 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.640.88 | 0.72 | 22.22% (+0.16) | |
| Jul 29, 2026 | 2026 (Q2) | 0.650.67 | 0.66 | 1.52% (+0.01) | |
| May 07, 2026 | 2026 (Q1) | 0.680.70 | 0.49 | 42.86% (+0.21) | |
| Feb 18, 2026 | 2025 (Q4) | 0.580.70 | 0.27 | 157.35% (+0.43) | |
| Oct 30, 2025 | 2025 (Q3) | 0.510.72 | 0.03 | 2300.00% (+0.69) | |
| Aug 04, 2025 | 2025 (Q2) | 0.570.66 | 0.57 | 15.79% (+0.09) | |
| May 05, 2025 | 2025 (Q1) | 0.230.49 | 0.49 | 0.00% (+0.00) | |
| Feb 18, 2025 | 2024 (Q4) | 0.400.27 | 0.5 | -45.60% (-0.23) | |
| Oct 31, 2024 | 2024 (Q3) | 0.050.03 | 0.32 | -90.63% (-0.29) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.


